B. Douglas Smith
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 126
- Acute Myeloid Leukemia Research 95
- Chronic Myeloid Leukemia Treatments 41
- Hematopoietic Stem Cell Transplantation 18
-
- Retinoids in leukemia and cellular processes 14
- Histone Deacetylase Inhibitors Research 13
- Co-authors
- Mark J. Levis (33 shared papers)Donald Small (10 shared papers)Judith E. Karp (44 shared papers)Richard J. Jones (33 shared papers)William Matsui (16 shared papers)Kathleen M. Murphy (5 shared papers)Karin D. Berg (2 shared papers)Hagop M. Kantarjian (6 shared papers)
- Journals
- Blood (56 papers)Clinical Cancer Research (9 papers)Leukemia Research (9 papers)Journal of Clinical Oncology (8 papers)Leukemia (7 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
B. Douglas Smith
166 papers receiving 6.2k citations
B. Douglas Smith's Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 4.2k
- Genetics 1.5k
- Oncology 1.3k
- Molecular Biology 2.8k
- Immunology 829
Countries citing papers authored by B. Douglas Smith
This map shows the geographic impact of B. Douglas Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Douglas Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Douglas Smith more than expected).
Fields of papers citing papers by B. Douglas Smith
This network shows the impact of papers produced by B. Douglas Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Douglas Smith. The network helps show where B. Douglas Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Douglas Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 481 | |
| 2 | 2002 | 378 | |
| 3 | Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome Hit paper breakdown → | 2018 | 354 |
| 4 | 2010 | 268 | |
| 5 | 2014 | 193 | |
| 6 | 2011 | 191 | |
| 7 | 2004 | 181 | |
| 8 | 2006 | 164 | |
| 9 | 2001 | 161 | |
| 10 | 2003 | 147 | |
| 11 | 2004 | 139 | |
| 12 | E-cadherin expression is silenced by 5' CpG island methylation in acute leukemia. | 2000 | 128 |
| 13 | 2012 | 124 | |
| 14 | 2011 | 111 | |
| 15 | 2005 | 109 | |
| 16 | 2007 | 97 | |
| 17 | 2005 | 96 | |
| 18 | 2010 | 83 | |
| 19 | 2007 | 83 | |
| 20 | 2011 | 82 |
About B. Douglas Smith
B. Douglas Smith is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 171 papers that have together received 6.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (95 papers), Chronic Myeloid Leukemia Treatments (41 papers), Chronic Lymphocytic Leukemia Research (32 papers), Acute Lymphoblastic Leukemia research (31 papers), Hematopoietic Stem Cell Transplantation (18 papers), Retinoids in leukemia and cellular processes (14 papers), Histone Deacetylase Inhibitors Research (13 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (13 papers). The work is most often cited by research in Hematology (4.2k citations), Genetics (1.5k citations), Oncology (1.3k citations), Molecular Biology (2.8k citations) and Immunology (829 citations). B. Douglas Smith has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Mark J. Levis, Donald Small, Judith E. Karp, Richard J. Jones, William Matsui, Kathleen M. Murphy, Karin D. Berg, Hagop M. Kantarjian, Robert A. Brodsky and Scott H. Kaufmann. Their work appears in journals such as Blood, Clinical Cancer Research, Leukemia Research, Journal of Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.